Skip to main content
OpenTrials

Clinical trial condition

Agressive Lymphoma

Explore clinical trials studying Agressive Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Agressive Lymphoma trial results

Completed

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT04231747

Conditions
Agressive Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse-large B-cell Lymphoma (DLBCL), +13 more
Locations
  • Local Institution - 003 Birmingham, Alabama, United States
  • Local Institution - 004 Atlanta, Georgia, United States
  • Local Institution - 011 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 14 locations
View Trial Details

Related conditions